Quarry LP’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.5K Buy
200
+180
+900% +$59.2K 0.01% 633
2025
Q4
$7.01K Sell
20
-173
-90% -$58.5K ﹤0.01% 1576
2025
Q3
$62.4K Buy
+193
New +$60K 0.01% 725
2025
Q2
Sell
-270
Closed -$117K 1811
2025
Q1
$117K Buy
+270
New +$108K 0.03% 463
2024
Q4
Sell
-503
Closed -$262K 1723
2024
Q3
$262K Buy
503
+369
+275% +$197K 0.07% 196
2024
Q2
$72.6K Buy
+134
New +$70.8K 0.02% 482
2024
Q1
Sell
-64
Closed -$30.2K 1711
2023
Q4
$30.2K Buy
+64
New +$29.6K ﹤0.01% 535
2023
Q2
Sell
-1,974
Closed -$908K 1149
2023
Q1
$908K Buy
1,974
+1,937
+5,235% +$922K 0.2% 94
2022
Q4
$19K Buy
+37
New +$18.8K ﹤0.01% 383

Other funds holding ELV

Quarry LP's ELV Position: Q1 2026 in Review

Quarry LP increased its Elevance Health (ELV) stake by 900% in Q1 2026, buying an estimated $59.2K and bringing the position to 200 shares worth $58.5K. The position accounts for 0.01% of the portfolio, ranked #633.

Quarry LP first reported a position in ELV in Q4 2022 and has held it in 9 quarters since. The position peaked at $908K in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Quarry LP held 200 shares of Elevance Health worth $58.5K as of Q1 2026.
  • Quarry LP bought 180 Elevance Health shares in Q1 2026, an estimated $59.2K.
  • Elevance Health made up 0.01% of Quarry LP's portfolio in Q1 2026, its #633 holding.
  • Quarry LP first reported a position in Elevance Health in Q4 2022 and has held it in 9 quarters since.
  • Quarry LP's Elevance Health position peaked at $908K in Q1 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.